These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 23602993)

  • 21. New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses.
    Williams RE; Mole SE
    Neurology; 2012 Jul; 79(2):183-91. PubMed ID: 22778232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuronal ceroid lipofuscinosis associated with an MFSD8 mutation in Chihuahuas.
    Ashwini A; D'Angelo A; Yamato O; Giordano C; Cagnotti G; Harcourt-Brown T; Mhlanga-Mutangadura T; Guo J; Johnson GS; Katz ML
    Mol Genet Metab; 2016 Aug; 118(4):326-32. PubMed ID: 27211611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis of the neuronal ceroid lipofuscinoses: an update.
    Williams RE; Aberg L; Autti T; Goebel HH; Kohlschütter A; Lönnqvist T
    Biochim Biophys Acta; 2006 Oct; 1762(10):865-72. PubMed ID: 16930952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A mixed breed dog with neuronal ceroid lipofuscinosis is homozygous for a CLN5 nonsense mutation previously identified in Border Collies and Australian Cattle Dogs.
    Villani NA; Bullock G; Michaels JR; Yamato O; O'Brien DP; Mhlanga-Mutangadura T; Johnson GS; Katz ML
    Mol Genet Metab; 2019 May; 127(1):107-115. PubMed ID: 31101435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent Insight into the Genetic Basis, Clinical Features, and Diagnostic Methods for Neuronal Ceroid Lipofuscinosis.
    Kaminiów K; Kozak S; Paprocka J
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The neuronal ceroid lipofuscinoses: the same, but different?
    Cooper JD
    Biochem Soc Trans; 2010 Dec; 38(6):1448-52. PubMed ID: 21118105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental Therapeutic Approaches for the Treatment of Retinal Pathology in Neuronal Ceroid Lipofuscinoses.
    Bartsch U; Storch S
    Front Neurol; 2022; 13():866983. PubMed ID: 35509995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The neuronal ceroid-lipofuscinoses: a historical introduction.
    Haltia M; Goebel HH
    Biochim Biophys Acta; 2013 Nov; 1832(11):1795-800. PubMed ID: 22959893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Canine neuronal ceroid lipofuscinoses: Promising models for preclinical testing of therapeutic interventions.
    Katz ML; Rustad E; Robinson GO; Whiting REH; Student JT; Coates JR; Narfstrom K
    Neurobiol Dis; 2017 Dec; 108():277-287. PubMed ID: 28860089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenesis and therapies for infantile neuronal ceroid lipofuscinosis (infantile CLN1 disease).
    Hawkins-Salsbury JA; Cooper JD; Sands MS
    Biochim Biophys Acta; 2013 Nov; 1832(11):1906-9. PubMed ID: 23747979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuronal ceroid lipofuscinoses: a review.
    Nardocci N; Cardona F
    Ital J Neurol Sci; 1998 Oct; 19(5):271-6. PubMed ID: 10933446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical aspects of neuronal ceroid lipofuscinoses.
    Tyynelä J; Suopanki J
    Neurol Sci; 2000; 21(3 Suppl):S21-5. PubMed ID: 11073224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A CLN8 nonsense mutation in the whole genome sequence of a mixed breed dog with neuronal ceroid lipofuscinosis and Australian Shepherd ancestry.
    Guo J; Johnson GS; Brown HA; Provencher ML; da Costa RC; Mhlanga-Mutangadura T; Taylor JF; Schnabel RD; O'Brien DP; Katz ML
    Mol Genet Metab; 2014 Aug; 112(4):302-9. PubMed ID: 24953404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neuronal ceroid lipofuscinoses].
    Augestad LB; Diderichsen J
    Tidsskr Nor Laegeforen; 2006 Aug; 126(15):1908-10. PubMed ID: 16915312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neuronal ceroid lipofuscinosis. Closing chapter of a long story].
    Elleder M
    Cesk Patol; 2000 May; 36(2):43-59. PubMed ID: 10916928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnostics and treatment of neuronal ceroid lipofuscinoses from the viewpoint of neuropediatricians].
    Steinfeld R
    Ophthalmologe; 2010 Jul; 107(7):616-20. PubMed ID: 20454899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell biology and function of neuronal ceroid lipofuscinosis-related proteins.
    Kollmann K; Uusi-Rauva K; Scifo E; Tyynelä J; Jalanko A; Braulke T
    Biochim Biophys Acta; 2013 Nov; 1832(11):1866-81. PubMed ID: 23402926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuronal ceroid lipofuscinoses type 8: Expanding genotype/phenotype diversity-first report from Saudi Arabia.
    Alkhars FZ; Bo Ali AY; Almohanna MA; Almajhad NA
    Neurosciences (Riyadh); 2020 Jan; 25(1):65-69. PubMed ID: 31982899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical and genetic description of neuronal ceroid lipofuscinosis 6 type in the yakut family].
    Golikova PI; Petukhova DA; Sukhomyasova AL; Nikolaeva TY; Gurinova EE; Ivanova RN; Maksimova NR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(8):71-76. PubMed ID: 34481439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Classification of the neuronal ceroid-lipofuscinoses: expansion of the atypical forms.
    Dyken P; Wisniewski K
    Am J Med Genet; 1995 Jun; 57(2):150-4. PubMed ID: 7668320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.